Skip to main content

Site notifications

We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.

Sub menu

News and events
Contact us
About us

Search

Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

You are here

Home
Resources and guidance
Sponsors

iX Biopharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (45)
Cancellation by sponsor (24)
Listed medicine compliance report (2)
Prescription medicine registration (1)

Date

2026 (2)
2025 (3)
2024 (6)
2023 (3)
2021 (12)
2020 (10)
2019 (11)
2018 (25)

Search

Sponsor content

72 result(s) found, displaying 61 to 70

PrenataliX Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by iX Biopharma Pty Ltd
MetaboliX Plus Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by iX Biopharma Pty Ltd
RejuveniX New Formulation Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by iX Biopharma Pty Ltd
Skin ProteX Cancelled under Section 30(1)(c) of the Act

2 April 2019

Cancellation by sponsor

Requested by iX Biopharma Pty Ltd
Skin ProteX Young Adults Cancelled under Section 30(1)(c) of the Act

2 April 2019

Cancellation by sponsor

Requested by iX Biopharma Pty Ltd
DermiX New Cancelled under Section 30(1)(c) of the Act

7 February 2019

Cancellation by sponsor

Requested by iX Biopharma Pty Ltd
MetaboliX Cancelled under Section 30(1)(c) of the Act

14 January 2019

Cancellation by sponsor

Requested by iX Biopharma Pty Ltd
FortefiX Plus Cancelled under Section 30(1)(c) of the Act

3 December 2018

Cancellation by sponsor

Requested by iX Biopharma Pty Ltd
MelaniX Cancelled under Section 30(1)(c) of the Act

10 October 2018

Cancellation by sponsor

Requested by iX Biopharma Pty Ltd
SILDENAFIL-ISPL, SILCAP, SILDENACAP (iX Biopharma Pty Ltd)

30 July 2018

Prescription medicine registration

Active ingredients: Sildenafil citrate.

Pages

First page
Previous page
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Current page 7
Page 8
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

© Commonwealth of Australia